Lamellar Biomedical Eyes Sales And Pipeline Growth With New Cash
Executive Summary
Scottish biotech Lamellar Biomedical has raised new cash to support commercialization of its pipeline of biomimetic products. The company's proprietary Lamellasome technology creates mimetics that replicate the actions of lamellar bodies to target diseases and conditions associated with thick sticky mucosal surfaces.